Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2025-06-06 to 2025-06-16
Current total value of award: $4075.5
Description: 8511427506!TYPHOID VI POLYSACC